Odonate, Inc. (ODTC)

Market Cap	53.25M
Revenue (ttm)	n/a
Net Income (ttm)	-102.07M
Shares Out	355.00
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	0
Open	150,000
Previous Close	140,000
Day's Range	150,000 - 150,000
52-Week Range	22,796 - 399,160
Beta	-0.10
RSI	54.04
Earnings Date	n/a

About Odonate

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.

• Industry: Shell Companies
• Sector: Financials
• Founded: 2013
• Employees: 145
• Stock Exchange: OTCMKTS
• Ticker Symbol: ODTC